Abstract
TCR-β Repertoire as a Source of Biomarkers for anti-PD1 Treatment Alone or in Combination With Chemotherapy in Advanced-stage NSCLC Patients
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have